ACELYRIN, INC Net Worth

ACELYRIN, INC Net Worth Breakdown

  SLRN
The net worth of ACELYRIN, INC Common is the difference between its total assets and liabilities. ACELYRIN, INC's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of ACELYRIN, INC's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. ACELYRIN, INC's net worth can be used as a measure of its financial health and stability which can help investors to decide if ACELYRIN, INC is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in ACELYRIN, INC Common stock.

ACELYRIN, INC Net Worth Analysis

ACELYRIN, INC's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including ACELYRIN, INC's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of ACELYRIN, INC's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform ACELYRIN, INC's net worth analysis. One common approach is to calculate ACELYRIN, INC's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares ACELYRIN, INC's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing ACELYRIN, INC's net worth. This approach calculates the present value of ACELYRIN, INC's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of ACELYRIN, INC's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate ACELYRIN, INC's net worth. This involves comparing ACELYRIN, INC's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into ACELYRIN, INC's net worth relative to its peers.
To determine if ACELYRIN, INC is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ACELYRIN, INC's net worth research are outlined below:
ACELYRIN, INC Common had very high historical volatility over the last 90 days
ACELYRIN, INC Common has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (381.64 M) with profit before overhead, payroll, taxes, and interest of 0.
ACELYRIN, INC generates negative cash flow from operations
ACELYRIN, INC Common has a poor financial position based on the latest SEC disclosures
Over 99.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Murugan Amar of 525000 shares of ACELYRIN, INC at 4.73 subject to Rule 16b-3
ACELYRIN, INC uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ACELYRIN, INC Common. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ACELYRIN, INC's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024
Upcoming Quarterly Report
View
20th of June 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Follow ACELYRIN, INC's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 458.49 M.

Market Cap

419.25 Million

Project ACELYRIN, INC's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.51)(0.54)
Return On Capital Employed(0.64)(0.67)
Return On Assets(0.51)(0.54)
Return On Equity(0.58)(0.55)
When accessing ACELYRIN, INC's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures ACELYRIN, INC's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ACELYRIN, INC's profitability and make more informed investment decisions.

Evaluate ACELYRIN, INC's management efficiency

ACELYRIN, INC Common has return on total asset (ROA) of (0.3289) % which means that it has lost $0.3289 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4195) %, meaning that it created substantial loss on money invested by shareholders. ACELYRIN, INC's management efficiency ratios could be used to measure how well ACELYRIN, INC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of November 2024, Return On Tangible Assets is likely to drop to -0.54. In addition to that, Return On Capital Employed is likely to drop to -0.67. At this time, ACELYRIN, INC's Other Assets are very stable compared to the past year. As of the 29th of November 2024, Other Current Assets is likely to grow to about 11.1 M, while Total Assets are likely to drop about 431.9 M.
Last ReportedProjected for Next Year
Book Value Per Share 9.34  9.81 
Tangible Book Value Per Share 9.34  9.81 
Enterprise Value Over EBITDA(0.81)(0.85)
Price Book Value Ratio 0.80  0.84 
Enterprise Value Multiple(0.81)(0.85)
Price Fair Value 0.80  0.84 
Enterprise Value276.4 M245.7 M
The strategic initiatives led by ACELYRIN, INC's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Return On Equity
(0.42)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ACELYRIN, INC insiders, such as employees or executives, is commonly permitted as long as it does not rely on ACELYRIN, INC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ACELYRIN, INC insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

ACELYRIN, INC Corporate Filings

F4
27th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
22nd of November 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
10Q
13th of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
ACELYRIN, INC time-series forecasting models is one of many ACELYRIN, INC's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ACELYRIN, INC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

ACELYRIN, INC Earnings per Share Projection vs Actual

ACELYRIN, INC Corporate Management

Patricia TurneyChief OfficerProfile
Kenneth LockChief OfficerProfile
Gilbert JDPrincipal OfficerProfile
Shephard MDSenior DevelopmentProfile
Kelly ChowChief OfficerProfile
Ron OystonChief OfficerProfile
When determining whether ACELYRIN, INC Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ACELYRIN, INC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Acelyrin, Inc Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Acelyrin, Inc Common Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ACELYRIN, INC Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACELYRIN, INC. If investors know ACELYRIN, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACELYRIN, INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.46)
Return On Assets
(0.33)
Return On Equity
(0.42)
The market value of ACELYRIN, INC Common is measured differently than its book value, which is the value of ACELYRIN, that is recorded on the company's balance sheet. Investors also form their own opinion of ACELYRIN, INC's value that differs from its market value or its book value, called intrinsic value, which is ACELYRIN, INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACELYRIN, INC's market value can be influenced by many factors that don't directly affect ACELYRIN, INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACELYRIN, INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if ACELYRIN, INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACELYRIN, INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.